Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

22.35

Margin Of Safety %

Put/Call OI Ratio

0.31

EPS Next Q Diff

-0.95

EPS Last/This Y

0.35

EPS This/Next Y

-0.33

Price

5.28

Target Price

16.86

Analyst Recom

1.75

Performance Q

45.45

Relative Volume

1.18

Beta

Ticker: ALT




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-17ALT4.20.240.18232070
2025-11-18ALT4.640.240.53234346
2025-11-19ALT4.590.230.26238365
2025-11-20ALT4.470.240.10239946
2025-11-21ALT4.80.230.05240957
2025-11-24ALT5.080.240.07224205
2025-11-25ALT5.140.240.16231537
2025-11-26ALT5.180.240.12235764
2025-12-01ALT4.930.240.54236948
2025-12-02ALT4.760.260.16243752
2025-12-03ALT5.140.260.18245660
2025-12-04ALT5.310.260.14247828
2025-12-05ALT5.240.260.34248714
2025-12-08ALT5.610.260.28241930
2025-12-09ALT5.50.260.46249690
2025-12-10ALT5.430.270.80256957
2025-12-11ALT5.320.280.96262955
2025-12-12ALT5.260.290.64263401
2025-12-15ALT5.260.311.01261716
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-17ALT4.2024.7-89.5-0.99
2025-11-18ALT4.6424.7-119.8-0.99
2025-11-19ALT4.5924.7-82.9-0.99
2025-11-20ALT4.4624.7-78.6-0.99
2025-11-21ALT4.7924.7-108.0-0.99
2025-11-24ALT5.0724.7-101.8-0.99
2025-11-25ALT5.1424.7-90.4-0.99
2025-11-26ALT5.1824.7-88.9-0.99
2025-12-01ALT4.9324.7-70.2-0.99
2025-12-02ALT4.7624.7-77.5-0.99
2025-12-03ALT5.1124.7-107.2-0.99
2025-12-04ALT5.3124.7-97.6-0.99
2025-12-05ALT5.2424.7-83.7-0.99
2025-12-08ALT5.6124.7- -0.99
2025-12-09ALT5.5224.7-83.3-0.99
2025-12-10ALT5.4324.7-82.3-0.99
2025-12-11ALT5.3324.7-82.6-0.99
2025-12-12ALT5.2624.7-83.4-0.99
2025-12-15ALT5.2824.7-87.3-0.99
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-17ALT0.00-1.0721.04
2025-11-18ALT0.00-1.0721.04
2025-11-19ALT0.00-1.0721.04
2025-11-20ALT0.00-1.0721.04
2025-11-21ALT0.00-1.0721.04
2025-11-24ALT0.003.9521.04
2025-11-25ALT0.003.9521.04
2025-11-26ALT0.003.9522.50
2025-12-01ALT0.003.9022.50
2025-12-02ALT0.003.9022.50
2025-12-03ALT0.003.9022.50
2025-12-04ALT0.003.9022.50
2025-12-05ALT0.003.9022.50
2025-12-08ALT0.003.9622.50
2025-12-09ALT0.003.9622.50
2025-12-10ALT0.003.9622.37
2025-12-11ALT0.003.9622.37
2025-12-12ALT0.003.9622.37
2025-12-15ALT0.003.9622.35
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ALT" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

0.67

Avg. EPS Est. Current Quarter

-0.25

Avg. EPS Est. Next Quarter

-0.28

Insider Transactions

Institutional Transactions

3.96

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

24

Growth Score

23

Sentiment Score

7

Actual DrawDown %

78.6

Max Drawdown 5-Year %

-91.2

Target Price

16.86

P/E

Forward P/E

PEG

P/S

27546.17

P/B

2.72

P/Free Cash Flow

EPS

-1.07

Average EPS Est. Cur. Y​

-0.99

EPS Next Y. (Est.)

-1.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-419575

Relative Volume

1.18

Return on Equity vs Sector %

-72.2

Return on Equity vs Industry %

-57.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.14

EBIT Estimation

-87.3
[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ALT” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALT” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALT” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALT” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALT” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALT” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALT” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune, Inc. Stock Price stock today
news today ALT – Altimmune, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune, Inc. yahoo finance google finance
stock history ALT – Altimmune, Inc. invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading